Australia's Immuron jumps on upbeat quarterly sales growth
** Shares of Immuron IMC.AX surge as much as 27.6% to A$0.037, their highest level since January 29, 2026 ** On track to log steepest intraday pct rise since July 17, 2025 ** Biopharmaceutical firm posts quarterly global sales of A$1.5 million ($1.07 million) for its immune supplement Travelen, 16% higher than a year ago ** About 2 million shares change hands, 8.7 times the 30-day avg ($1 = 1.3965 Australian dollars) (Reporting by Anjali Singh in Bengaluru) ((anjali.singh2@thomsonreuters.com;))
Recent news on Immuron
See all newsBrief: Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
Australia's Immuron hits near 1.5-month high on distribution deal in US
Brief: Immuron Executes Exclusive Distribution Agreement For Proibs In The United States
Brief: Immuron Reports FY26 Preliminary Results
Brief: Immuron Posts FY Revenue From Ordinary Activities Of A$7.71 Million